Written by Swikblog Health Desk
Published: 1 December 2025
Australia’s medicines watchdog has issued a fresh safety warning for Ozempic and other blockbuster weight-loss injections, telling doctors and patients to watch for serious mental-health side effects, including depression and suicidal thoughts. The alert covers the full class of GLP-1 receptor agonists, widely prescribed for type 2 diabetes and increasingly used off-label for rapid weight loss.
The Therapeutic Goods Administration (TGA) said product information for medicines such as Ozempic, Wegovy, Saxenda and Mounjaro will now highlight the potential for suicidal ideation, suicide attempts and self-harm. Regulators reviewed Australian and international reports of people experiencing new or worsening mood changes after starting a GLP-1 drug, prompting a class-wide safety update.
What triggered the Ozempic warning in Australia?
The move follows a surge in prescriptions and a parallel rise in adverse-event reports as “Ozempic Australia” and “Ozempic side effects” trend across search and social media. According to the TGA, a number of cases have involved people reporting sudden dark thoughts, anxiety or intense emotional swings while using GLP-1 injections.
While the regulator stresses that the current evidence does not prove these drugs directly cause suicide or self-harm, it says the signal is strong enough to justify clearer warnings. The updated advice urges prescribers to ask about a patient’s mental-health history before starting treatment and to monitor closely for any changes once injections begin. Full details are available in the TGA safety update for GLP-1 medicines, published on the agency’s website and updated in line with overseas regulators such as the European Medicines Agency and the US Food and Drug Administration.
What does this mean for people using Ozempic and other GLP-1 jabs?
For Australians currently injecting Ozempic, Wegovy or similar medications, the key message is do not stop suddenly without medical advice. These drugs can be very effective for blood-sugar control and significant weight loss, and for many people the benefits still outweigh the risks. However, the TGA now recommends that patients, friends and family stay alert to warning signs such as:
- New or worsening feelings of depression or hopelessness
- Thoughts of self-harm or suicide
- Unusual behaviour changes, agitation or marked mood swings
Anyone noticing these symptoms is urged to seek immediate medical help. In an emergency, Australians can contact Lifeline on 13 11 14 or call triple-zero (000). The TGA also encourages patients to report suspected side effects via its official reporting portal so regulators can track emerging safety signals in real time.
Why mental health must be part of the weight-loss conversation
The warning lands at a moment when demand for “skinny jabs” is reshaping pharmacies from Sydney to Perth. For many people living with obesity, GLP-1 medicines promise better blood-sugar control, less joint pain and lower heart-disease risk. Yet rapid weight loss can also be emotionally complex, especially for people with a history of body-image issues, eating disorders or depression.
Experts say that as powerful new drugs roll out, they must be paired with psychological support and realistic expectations. International regulators, including the FDA in the United States, are still reviewing data on suicidal thoughts linked to GLP-1 drugs, but have so far not found clear evidence of a higher overall risk compared with other treatments. Even so, they echo Australia’s call for vigilance and shared decision-making between patients and clinicians.
Looking ahead: tighter rules and better information
The TGA’s move is unlikely to kill demand for Ozempic-style injections in Australia, but it does change the conversation. Future advertising and influencer promotion of GLP-1 weight-loss drugs is expected to face tougher scrutiny, while GPs may become more cautious when prescribing to younger adults or those already being treated for mental-health conditions.
For readers tracking what else is trending beyond health, Swikblog is also following major sporting moments such as the North London derby showdown, which recently sparked huge traffic from Australia and New Zealand.
Important: This article is for general information only and is not a substitute for professional medical advice. Always talk to your doctor or pharmacist before starting, stopping or changing any medication.
